Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 427


Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection.

Kim K, Perera R, Tan DB, Fernandez S, Seddiki N, Waring J, French MA.

Tuberculosis (Edinb). 2014 Sep;94(5):494-501. doi: 10.1016/ Epub 2014 Jul 17.


Characterization of CD4/CD8+ αβ and Vγ2Vδ2+ T cells in HIV-negative individuals with different Mycobacterium tuberculosis infection statuses.

Gao Y, Zhang S, Ou Q, Shen L, Wang S, Wu J, Weng X, Chen ZW, Zhang W, Shao L.

Hum Immunol. 2015 Nov;76(11):801-7. doi: 10.1016/j.humimm.2015.09.039. Epub 2015 Sep 30.


Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis.

Marin ND, París SC, Vélez VM, Rojas CA, Rojas M, García LF.

Tuberculosis (Edinb). 2010 Jul;90(4):252-61. doi: 10.1016/ Epub 2010 Jul 1.


A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis.

Ribeiro-Rodrigues R, Resende Co T, Rojas R, Toossi Z, Dietze R, Boom WH, Maciel E, Hirsch CS.

Clin Exp Immunol. 2006 Apr;144(1):25-34.


T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.

Nemeth J, Winkler HM, Karlhofer F, Selenko-Gebauer N, Graninger W, Winkler S.

Eur Cytokine Netw. 2010 Mar;21(1):34-9. doi: 10.1684/ecn.2009.0182.


Effective expansion of forkhead box P3⁺ regulatory T cells via early secreted antigenic target 6 and antigen 85 complex B from Mycobacterium tuberculosis.

Wu YE, Du ZR, Cai YM, Peng WG, Zheng GZ, Zheng GL, Wu LB, Li K.

Mol Med Rep. 2015 Apr;11(4):3134-42. doi: 10.3892/mmr.2014.3033. Epub 2014 Dec 3.


Multi-functional flow cytometry analysis of CD4+ T cells as an immune biomarker for latent tuberculosis status in patients treated with tumour necrosis factor (TNF) antagonists.

Sauzullo I, Scrivo R, Mengoni F, Ermocida A, Coppola M, Valesini G, Vullo V, Mastroianni CM.

Clin Exp Immunol. 2014 Jun;176(3):410-7. doi: 10.1111/cei.12290.


Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients.

Chiacchio T, Petruccioli E, Vanini V, Cuzzi G, Pinnetti C, Sampaolesi A, Antinori A, Girardi E, Goletti D.

J Infect. 2014 Dec;69(6):533-45. doi: 10.1016/j.jinf.2014.06.009. Epub 2014 Jun 26.


Cytokine response to selected MTB antigens in Ghanaian TB patients, before and at 2 weeks of anti-TB therapy is characterized by high expression of IFN-γ and Granzyme B and inter- individual variation.

Mensah GI, Addo KK, Tetteh JA, Sowah S, Loescher T, Geldmacher C, Jackson-Sillah D.

BMC Infect Dis. 2014 Sep 10;14:495. doi: 10.1186/1471-2334-14-495.


Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.

Hur YG, Gorak-Stolinska P, Ben-Smith A, Lalor MK, Chaguluka S, Dacombe R, Doherty TM, Ottenhoff TH, Dockrell HM, Crampin AC.

PLoS One. 2013 Nov 18;8(11):e79742. doi: 10.1371/journal.pone.0079742. eCollection 2013.


Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.

Adekambi T, Ibegbu CC, Kalokhe AS, Yu T, Ray SM, Rengarajan J.

PLoS One. 2012;7(4):e36046. doi: 10.1371/journal.pone.0036046. Epub 2012 Apr 24.


Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.

Hamdi H, Mariette X, Godot V, Weldingh K, Hamid AM, Prejean MV, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Delchier JC, Flipo RM, Dautzenberg B, Salmon D, Humbert M, Emilie D; RATIO (Recherche sur Anti-TNF et Infections Opportunistes) Study Group.

Arthritis Res Ther. 2006;8(4):R114.


Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.

Borgström E, Andersen P, Atterfelt F, Julander I, Källenius G, Maeurer M, Rosenkrands I, Widfeldt M, Bruchfeld J, Gaines H.

PLoS One. 2012;7(11):e43438. doi: 10.1371/journal.pone.0043438. Epub 2012 Nov 8.


Regulatory T-cell subsets in response to specific Mycobacterium tuberculosis antigens in vitro distinguish among individuals with different QTF and TST reactivity.

Serrano CJ, Castañeda-Delgado JE, Trujillo-Ochoa JL, González-Amaro R, García-Hernández MH, Enciso-Moreno JA.

Clin Immunol. 2015 Apr;157(2):145-55. doi: 10.1016/j.clim.2015.02.008. Epub 2015 Feb 26.


Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood.

Chiacchio T, Petruccioli E, Vanini V, Butera O, Cuzzi G, Petrone L, Matteucci G, Lauria FN, Franken KL, Girardi E, Ottenhoff TH, Goletti D.

PLoS One. 2011;6(11):e27539. doi: 10.1371/journal.pone.0027539. Epub 2011 Nov 10.


Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis.

Chiacchio T, Casetti R, Butera O, Vanini V, Carrara S, Girardi E, Di Mitri D, Battistini L, Martini F, Borsellino G, Goletti D.

Clin Exp Immunol. 2009 Jun;156(3):463-70. doi: 10.1111/j.1365-2249.2009.03908.x.


PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection.

Pollock KM, Montamat-Sicotte DJ, Grass L, Cooke GS, Kapembwa MS, Kon OM, Sampson RD, Taylor GP, Lalvani A.

PLoS One. 2016 Jan 12;11(1):e0146905. doi: 10.1371/journal.pone.0146905. eCollection 2016.


Patients with tuberculosis disease have Mycobacterium tuberculosis-specific CD8 T cells with a pro-apoptotic phenotype and impaired proliferative capacity, which is not restored following treatment.

Day CL, Moshi ND, Abrahams DA, van Rooyen M, O'rie T, de Kock M, Hanekom WA.

PLoS One. 2014 Apr 16;9(4):e94949. doi: 10.1371/journal.pone.0094949. eCollection 2014.


Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.

Mattos AM, Almeida Cde S, Franken KL, Alves CC, Abramo C, de Souza MA, L'Hotellier M, Alves MJ, Ferreira AP, Oliveira SC, Ottenhoff TH, Teixeira HC.

Int Immunol. 2010 Sep;22(9):775-82. doi: 10.1093/intimm/dxq429. Epub 2010 Jul 11.


Supplemental Content

Support Center